Literature DB >> 18446168

In situ mouse carotid perfusion model: glucose and cholesterol transport in the eye and brain.

Julie Cattelotte1, Pascal André, Mélissa Ouellet, Fanchon Bourasset, Jean-Michel Scherrmann, Salvatore Cisternino.   

Abstract

The in situ mouse brain perfusion method for measuring blood-brain barrier permeability was adapted to assess transport of solutes at the blood-brain and blood-eye barriers. The procedure was checked with radiolabeled markers in oxygenated bicarbonate-buffered fluid infused for 30 to 120 sec via a carotid artery. Vascular flow estimated with diazepam was 2.2-fold lower in the eye than in the brain. The vascular volume and the integrity markers sucrose and inulin indicated that a perfusion flow rate of 2.5 mL/min preserved the physical integrity of these organs. However, the brain vasculature integrity was more sensitive to acute perfusion pressure than the eye vasculature. The functional capacities of blood barriers were assessed with D-glucose; its transport followed Michaelis-Menten kinetics with an apparent K(m) of 7.6 mmol/L and a V(max) of 23 micromol/sec per g in the brain, and a K(m) of 22.9 mmol/L and a V(max) of 40 micromol/sec per g in the eye. The transport of cholesterol to the brain and eye was significantly enhanced by adding the Abca1 inhibitor probucol, suggesting an Abca1-mediated efflux at the mouse brain and eye blood barriers. Thus in situ carotid perfusion is suitable for elucidating transport processes at the blood-brain and blood-eye barriers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446168     DOI: 10.1038/jcbfm.2008.34

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  19 in total

1.  Discrepancies in the P-glycoprotein-mediated transport of (18)F-MPPF: a pharmacokinetic study in mice and non-human primates.

Authors:  Nicolas Tournier; Salvatore Cisternino; Marie-Anne Peyronneau; Sébastien Goutal; Frédéric Dolle; Jean-Michel Scherrmann; Michel Bottlaender; Wadad Saba; Héric Valette
Journal:  Pharm Res       Date:  2012-05-30       Impact factor: 4.200

2.  A polyspecific drug/proton antiporter mediates diphenhydramine and clonidine transport at the mouse blood-retinal barrier.

Authors:  Hélène Chapy; Pascal André; Xavier Declèves; Jean-Michel Scherrmann; Salvatore Cisternino
Journal:  Br J Pharmacol       Date:  2015-08-10       Impact factor: 8.739

Review 3.  Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.

Authors:  Dharmini C Mehta; Jennifer L Short; Sarah N Hilmer; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

4.  Direct evidence of abca1-mediated efflux of cholesterol at the mouse blood-brain barrier.

Authors:  Tuan Minh Do; Mélissa Ouellet; Frédéric Calon; Giovanna Chimini; Hélène Chacun; Robert Farinotti; Fanchon Bourasset
Journal:  Mol Cell Biochem       Date:  2011-06-10       Impact factor: 3.396

5.  Altered brain uptake of therapeutics in a triple transgenic mouse model of Alzheimer's disease.

Authors:  Dharmini C Mehta; Jennifer L Short; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2013-06-22       Impact factor: 4.200

6.  Effects of selected OATP and/or ABC transporter inhibitors on the brain and whole-body distribution of glyburide.

Authors:  Nicolas Tournier; Wadad Saba; Salvatore Cisternino; Marie-Anne Peyronneau; Annelaure Damont; Sébastien Goutal; Albertine Dubois; Frédéric Dollé; Jean-Michel Scherrmann; Héric Valette; Bertrand Kuhnast; Michel Bottlaender
Journal:  AAPS J       Date:  2013-08-02       Impact factor: 4.009

7.  Influence of P-Glycoprotein Inhibition or Deficiency at the Blood-Brain Barrier on (18)F-2-Fluoro-2-Deoxy-D-glucose ( (18)F-FDG) Brain Kinetics.

Authors:  Nicolas Tournier; Wadad Saba; Sébastien Goutal; Philippe Gervais; Héric Valette; Jean-Michel Scherrmann; Michel Bottlaender; Salvatore Cisternino
Journal:  AAPS J       Date:  2015-02-26       Impact factor: 4.009

8.  Coexistence of passive and proton antiporter-mediated processes in nicotine transport at the mouse blood-brain barrier.

Authors:  Salvatore Cisternino; Hélène Chapy; Pascal André; Maria Smirnova; Marcel Debray; Jean-Michel Scherrmann
Journal:  AAPS J       Date:  2012-12-05       Impact factor: 4.009

9.  Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier.

Authors:  Hélène Chapy; Bruno Saubaméa; Nicolas Tournier; Fanchon Bourasset; Francine Behar-Cohen; Xavier Declèves; Jean-Michel Scherrmann; Salvatore Cisternino
Journal:  Br J Pharmacol       Date:  2016-01-15       Impact factor: 8.739

10.  Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties.

Authors:  Marianne Seleman; Hélène Chapy; Salvatore Cisternino; Cindie Courtin; Maria Smirnova; Joël Schlatter; Fouad Chiadmi; Jean-Michel Scherrmann; Florence Noble; Cynthia Marie-Claire
Journal:  Psychopharmacology (Berl)       Date:  2014-04-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.